New drugs focus on recent therapies for larger patient populations
![](/content/hub5/drug-pipeline-insights-report-summer-2023/_jcr_content/root/container/container/column_half/col1/o4_adaptiveimage.jpg)
Welcome to the next issue of Drugs to Watch for 2023
In this Drug Pipeline Insights Report, we review:
- Fast-acting treatment for postpartum depression
- The first treatment approved to prevent blindness due to geographic atrophy
- Relief from moderate-to-severe atopic dermatitis
Don't want to read the full report? Download the brief summary.
Related Content
![](/content/dam/optum4/resources/images/two-pharmacists-working-1080x720.jpg)
3 new first-in-class therapies coming
See how innovation is driving the latest product development.
![](/content/dam/o4-dam/images/professionals/pharmacies/man-signing-paper-1080x720.jpg)
Rules impacting pharmacy: Summer 2023 legislative sessions
Learn what's at stake as the Senate considers PBM legislation.
![](/content/dam/optum4/resources/images/wf9173219_winterdrugswatch_social_image_1080x720.jpg)
4 new drugs to watch this year
Breakthrough treatments for menopause, Alzheimer's and hemophilia are coming.